STOCKHOLDERS AGREEMENTStockholders Agreement • June 21st, 2013 • Feinberg Family Trust • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJune 21st, 2013 Company Industry JurisdictionThis STOCKHOLDERS AGREEMENT (the “Agreement”) is made as of May 13, 2013 by and among Vermillion, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Jack W. Schuler (“Schuler” and together with Oracle, the “Principal Purchasers”) and the other purchasers named in the Purchase Agreement (as defined below) (collectively, the “Purchasers”).
STOCKHOLDERS AGREEMENTStockholders Agreement • May 23rd, 2013 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 23rd, 2013 Company Industry JurisdictionThis STOCKHOLDERS AGREEMENT (the “Agreement”) is made as of May 13, 2013 by and among Vermillion, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Jack W. Schuler (“Schuler” and together with Oracle, the “Principal Purchasers”) and the other purchasers named in the Purchase Agreement (as defined below) (collectively, the “Purchasers”).
STOCKHOLDERS AGREEMENTStockholders Agreement • May 14th, 2013 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 14th, 2013 Company Industry JurisdictionThis STOCKHOLDERS AGREEMENT (the “Agreement”) is made as of May 13, 2013 by and among Vermillion, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Jack W. Schuler (“Schuler” and together with Oracle, the “Principal Purchasers”) and the other purchasers named in the Purchase Agreement (as defined below) (collectively, the “Purchasers”).